TY -的T1 ICS-formoterol ste释放治疗pwise treatment algorithm for adult asthma JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01407-2019 VL - 55 IS - 1 SP - 1901407 AU - Beasley, Richard AU - Braithwaite, Irene AU - Semprini, Alex AU - Kearns, Ciléin AU - Weatherall, Mark AU - Harrison, Tim W. AU - Papi, Alberto AU - Pavord, Ian D. Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/55/1/1901407.abstract N2 - A stepwise approach to the pharmacological treatment of asthma is a key feature of current asthma guidelines [1–4]. Through algorithms, treatment intensity is “stepped up” to obtain asthma control and reduce the risk of exacerbations, and “stepped down” after a period of prolonged control and absence of exacerbations. Traditional algorithms advocated short-acting β2-agonist (SABA) reliever therapy for all levels of severity, initially as sole therapy at Step 1, together with maintenance “low dose” inhaled corticosteroids (ICS) at Step 2, with maintenance ICS/long-acting β2-agonist (LABA) at “low”, “moderate” or “high” doses at Steps 3 and 4, and finally with “add-on” therapies at Step 5.A practical “anti-inflammatory reliever therapy”-based algorithm based on the GINA 2019 update is presented, together with a prototype action plan to facilitate its implementation. http://bit.ly/33C2s5u ER -